9651149

Source:http://linkedlifedata.com/resource/pubmed/id/9651149

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003779, umls-concept:C0053139, umls-concept:C0162829, umls-concept:C0205177, umls-concept:C0205531, umls-concept:C0226896, umls-concept:C0442027, umls-concept:C0682756, umls-concept:C0914884, umls-concept:C1527415
pubmed:issue	14
pubmed:dateCreated	1998-7-24
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9716531
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Arginine Vasopressin, http://linkedlifedata.com/resource/pubmed/chemical/Azepines, http://linkedlifedata.com/resource/pubmed/chemical/Benzamides, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasopressin, http://linkedlifedata.com/resource/pubmed/chemical/Sodium
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0022-2623
pubmed:author	pubmed-author:AlbrightJ DJD, pubmed-author:BaileyTT, pubmed-author:ChanP SPS, pubmed-author:CoupetJJ, pubmed-author:Delos SantosE GEG, pubmed-author:DuszaJ PJP, pubmed-author:MazandaraniHH, pubmed-author:ReichM FMF, pubmed-author:SUYY, pubmed-author:SumF WFW, pubmed-author:VenkatesanA MAM
pubmed:issnType	Print
pubmed:day	2
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2442-4
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:9651149-Administration, Oral, pubmed-meshheading:9651149-Animals, pubmed-meshheading:9651149-Arginine Vasopressin, pubmed-meshheading:9651149-Azepines, pubmed-meshheading:9651149-Benzamides, pubmed-meshheading:9651149-Blood Platelets, pubmed-meshheading:9651149-Body Water, pubmed-meshheading:9651149-Cell Line, pubmed-meshheading:9651149-Cell Membrane, pubmed-meshheading:9651149-Dogs, pubmed-meshheading:9651149-Fibroblasts, pubmed-meshheading:9651149-Humans, pubmed-meshheading:9651149-Kidney, pubmed-meshheading:9651149-Liver, pubmed-meshheading:9651149-Osmolar Concentration, pubmed-meshheading:9651149-Pyrroles, pubmed-meshheading:9651149-Rats, pubmed-meshheading:9651149-Receptors, Vasopressin, pubmed-meshheading:9651149-Sodium, pubmed-meshheading:9651149-Structure-Activity Relationship, pubmed-meshheading:9651149-Urine
pubmed:year	1998
pubmed:articleTitle	5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors.
pubmed:affiliation	Wyeth-Ayerst Research, Pearl River, New York 10965, and Wyeth-Ayerst Research, Princeton, New Jersey 08543-8000, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial